Sheng-Xiang Rao1, Doenja Mj Lambregts2, Roald S Schnerr2, Wenzel van Ommen3, Thiemo Ja van Nijnatten2, Milou H Martens4, Luc A Heijnen4, Walter H Backes2, Cornelis Verhoef5, Meng-Su Zeng6, Geerard L Beets7, Regina Gh Beets-Tan8. 1. Department of Radiology, Maastricht University Medical Center, The Netherlands ; Department of Radiology, Zhongshan Hospital, Fudan University, China. 2. Department of Radiology, Maastricht University Medical Center, The Netherlands. 3. Department of Radiology, Maastricht University Medical Center, The Netherlands ; Department of Radiology, Catharina Hospital Eindhoven, The Netherlands. 4. Department of Radiology, Maastricht University Medical Center, The Netherlands ; Department of Surgery, Maastricht University Medical Center, The Netherlands. 5. Department of Surgical Oncology, Erasmus MC Cancer Institute, The Netherlands. 6. Department of Radiology, Zhongshan Hospital, Fudan University, China. 7. Department of Surgery, Maastricht University Medical Center, The Netherlands ; GROW School for Oncology and Developmental Biology, The Netherlands. 8. Department of Radiology, Maastricht University Medical Center, The Netherlands ; GROW School for Oncology and Developmental Biology, The Netherlands.
Abstract
BACKGROUND: Liver metastases limit survival in colorectal cancer. Earlier detection of (occult) metastatic disease may benefit treatment and survival. OBJECTIVE: The objective of this article is to evaluate the potential of whole-liver CT texture analysis of apparently disease-free liver parenchyma for discriminating between colorectal cancer (CRC) patients with and without hepatic metastases. METHODS: The primary staging CT examinations of 29 CRC patients were retrospectively analysed. Patients were divided into three groups: patients without liver metastases (n = 15), with synchronous liver metastases (n = 10) and metachronous liver metastases within 18 months following primary staging (n = 4). Whole-liver texture analysis was performed by delineation of the apparently non-diseased liver parenchyma (excluding metastases or other focal liver lesions) on portal phase images. Mean grey-level intensity (M), entropy (E) and uniformity (U) were derived with no filtration and different filter widths (0.5 = fine, 1.5 = medium, 2.5 = coarse). RESULTS: Mean E1.5 and E2.5 for the whole liver in patients with synchronous metastases were significantly higher compared with the non-metastatic patients (p = 0.02 and p = 0.01). Mean U1.5 and U2.5 were significantly lower in the synchronous metastases group compared with the non-metastatic group (p = 0.04 and p = 0.02). Texture parameters for the metachronous metastases group were not significantly different from the non-metastatic group or synchronous metastases group (p > 0.05), although - similar to the synchronous metastases group - there was a subtle trend towards increased E1.5, E2.5 and decreased U1.5, U2.5 values. Areas under the ROC curve for the diagnosis of synchronous metastatic disease based on the texture parameters E1.5,2.5 and U1.5,2.5 ranged between 0.73 and 0.78. CONCLUSION: Texture analysis of the apparently non-diseased liver holds promise to differentiate between CRC patients with and without metastatic liver disease. Further research is required to determine whether these findings may be used to benefit the prediction of metachronous liver disease.
BACKGROUND:Liver metastases limit survival in colorectal cancer. Earlier detection of (occult) metastatic disease may benefit treatment and survival. OBJECTIVE: The objective of this article is to evaluate the potential of whole-liver CT texture analysis of apparently disease-free liver parenchyma for discriminating between colorectal cancer (CRC) patients with and without hepatic metastases. METHODS: The primary staging CT examinations of 29 CRC patients were retrospectively analysed. Patients were divided into three groups: patients without liver metastases (n = 15), with synchronous liver metastases (n = 10) and metachronous liver metastases within 18 months following primary staging (n = 4). Whole-liver texture analysis was performed by delineation of the apparently non-diseased liver parenchyma (excluding metastases or other focal liver lesions) on portal phase images. Mean grey-level intensity (M), entropy (E) and uniformity (U) were derived with no filtration and different filter widths (0.5 = fine, 1.5 = medium, 2.5 = coarse). RESULTS: Mean E1.5 and E2.5 for the whole liver in patients with synchronous metastases were significantly higher compared with the non-metastatic patients (p = 0.02 and p = 0.01). Mean U1.5 and U2.5 were significantly lower in the synchronous metastases group compared with the non-metastatic group (p = 0.04 and p = 0.02). Texture parameters for the metachronous metastases group were not significantly different from the non-metastatic group or synchronous metastases group (p > 0.05), although - similar to the synchronous metastases group - there was a subtle trend towards increased E1.5, E2.5 and decreased U1.5, U2.5 values. Areas under the ROC curve for the diagnosis of synchronous metastatic disease based on the texture parameters E1.5,2.5 and U1.5,2.5 ranged between 0.73 and 0.78. CONCLUSION: Texture analysis of the apparently non-diseased liver holds promise to differentiate between CRC patients with and without metastatic liver disease. Further research is required to determine whether these findings may be used to benefit the prediction of metachronous liver disease.
Authors: Carlo Pulitanò; Federico Castillo; Luca Aldrighetti; Martin Bodingbauer; Rowan W Parks; Gianfranco Ferla; Stephen J Wigmore; O James Garden Journal: HPB (Oxford) Date: 2010-05 Impact factor: 3.647
Authors: Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Vladimir A Valera; Pavel V Korita; Kouhei Akazawa; Yoichi Ajioka; Katsuyoshi Hatakeyama Journal: Ann Surg Oncol Date: 2008-07-02 Impact factor: 5.344
Authors: Joachim Hohmann; Christine Müller; Anja Oldenburg; Jan Skrok; Bernd B Frericks; Karl-Jürgen Wolf; Thomas Albrecht Journal: Ultrasound Med Biol Date: 2009-06-21 Impact factor: 2.998
Authors: Ahmad Chaddad; Christian Desrosiers; Ahmed Bouridane; Matthew Toews; Lama Hassan; Camel Tanougast Journal: PLoS One Date: 2016-02-22 Impact factor: 3.240
Authors: Marco Ravanelli; Giorgio Maria Agazzi; Elena Tononcelli; Elisa Roca; Paolo Cabassa; Gianluca Baiocchi; Alfredo Berruti; Roberto Maroldi; Davide Farina Journal: Radiol Med Date: 2019-06-06 Impact factor: 3.469
Authors: Sheng-Xiang Rao; Doenja Mj Lambregts; Roald S Schnerr; Rianne Cj Beckers; Monique Maas; Fabrizio Albarello; Robert G Riedl; Cornelis Hc Dejong; Milou H Martens; Luc A Heijnen; Walter H Backes; Geerard L Beets; Meng-Su Zeng; Regina Gh Beets-Tan Journal: United European Gastroenterol J Date: 2015-08-21 Impact factor: 4.623
Authors: Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris Journal: J Magn Reson Imaging Date: 2017-11-02 Impact factor: 4.813
Authors: Amber L Simpson; Alexandre Doussot; John M Creasy; Lauryn B Adams; Peter J Allen; Ronald P DeMatteo; Mithat Gönen; Nancy E Kemeny; T Peter Kingham; Jinru Shia; William R Jarnagin; Richard K G Do; Michael I D'Angelica Journal: Ann Surg Oncol Date: 2017-05-30 Impact factor: 5.344
Authors: Scott J Lee; Ryan Zea; David H Kim; Meghan G Lubner; Dustin A Deming; Perry J Pickhardt Journal: Eur Radiol Date: 2017-11-21 Impact factor: 5.315
Authors: Pier Paolo Mainenti; Federica Romano; Laura Pizzuti; Sabrina Segreto; Giovanni Storto; Lorenzo Mannelli; Massimo Imbriaco; Luigi Camera; Simone Maurea Journal: World J Radiol Date: 2015-07-28